Kyphon to Showcase Continued Product Innovation at 21st Annual Meeting of North American Spine Society
September 26 2006 - 9:17PM
PR Newswire (US)
275,000 Spinal Fractures Have Now Been Treated Using Balloon
Kyphoplasty SUNNYVALE, Calif., Sept. 26 /PRNewswire-FirstCall/ --
Kyphon Inc. (NASDAQ:KYPH) announced today that it will showcase a
series of new products at the 21st annual meeting of the North
American Spine Society (NASS) on September 27-29, 2006 at the
Washington State Convention Center in Seattle, Washington. Kyphon's
products will be on display in booth #406. The Company's continued
expansion of the balloon kyphoplasty product suite has resulted in
the new KyphX(R) Latitude II(TM) Curette, which will be formally
launched at NASS. This product represents significant advancements
in Kyphon's curette franchise, featuring improvements in ease of
use and mechanical deployment that assist spine specialists in
treating vertebral compression fractures. In addition, the Company
will provide expanded information regarding its recently launched
products, including the larger KyphX(R) Express(TM) Inflatable Bone
Tamp and the KyphX(R) Directional Bone Filler Devices. This year's
conference will also be the first NASS meeting at which Kyphon will
promote its Discyphor(TM) Catheter System, used in performing
Functional Anaesthetic Discography(TM) (F.A.D.) procedures for
diagnosing discogenic pain. Over 300 F.A.D. procedures have been
performed on over 400 intervertebral discs suspected of causing low
back pain. "Our Kyphoplasty products have now been used in the
treatment of over 275,000 spinal fractures worldwide, which is
clear evidence that balloon kyphoplasty is rapidly becoming the
treatment standard of choice for patients with spinal compression
fractures due to osteoporosis or cancer," commented Richard Mott,
president and chief executive officer of Kyphon. "I am excited that
Kyphon will be able to showcase our progress in expanding our
product portfolio for the treatment of spinal fractures and
diagnosis of discogenic pain at NASS. We believe the positive
feedback we have received from clinicians who have used the
Latitude II Curette and the Discyphor Catheter System for
Functional Anaesthetic Discography further validates their clinical
value." About Kyphon Inc. Kyphon develops and markets medical
devices designed to restore spinal function using minimally
invasive technologies. The company's KyphX line of products is used
in balloon kyphoplasty, a minimally invasive procedure to treat
spinal fractures caused by osteoporosis or cancer. More information
about the company can be found at http://www.kyphon.com/ . NOTE:
Latitude, Latitude II, Express, Discyphor, and Functional
Anaesthetic Discography are trademarks, and Kyphon and KyphX are
registered trademarks, of Kyphon Inc. This press release contains
forward-looking statements within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995. Forward looking
statements include, but are not limited to, those that use words
such as "believes," "expects," "anticipates," "targets," "intends,"
"plans," "projects," and words of similar effect, and specifically
include the company's future financial projections and anticipated
business direction and performance. Forward-looking statements are
based on management's current preliminary expectations and are
subject to risks, uncertainties and assumptions, which may cause
the company's actual results to differ materially from the
statements contained herein. Information on potential risk factors
that could affect Kyphon, its business and its financial results
are detailed in the company's periodic filings with the Securities
and Exchange Commission (SEC), including, but not limited to, those
risks and uncertainties listed in the section entitled
"Management's Discussion and Analysis of Financial Condition and
Results of Operations - Factors Affecting Future Operating
Results," which can be found in Kyphon's annual report on Form 10-K
for the year ended December 31, 2005 filed with the SEC on March 3,
2006 and in Kyphon's quarterly report on Form 10-Q for the quarter
ended June 30, 2006 filed with the SEC on August 8, 2006. Kyphon
undertakes no obligation to release publicly any revisions to any
forward-looking statements contained herein to reflect events or
circumstances after the date hereof. KYPHG DATASOURCE: Kyphon Inc.
CONTACT: Investors and Media, Julie D. Tracy, Vice President,
Investor Relations and Corporate Marketing of Kyphon Inc.,
+1-408-548-6500, or Web site: http://www.kyphon.com/
Copyright
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Jul 2023 to Jul 2024